ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,572Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1448

$1.19M Total Retail Price of All Prescriptions

Rank: 20 out of 1448

937 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 18,936 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,257 1,249 1 2
ISOSORBIDE MONONITRATE ER 957 939 2 16
SOTALOL 765 737 10 3 40
AMIODARONE HCL 735 705 10 4 22
DIGOXIN 616 594 5 13
PLAVIX 509 506 6 14
ATORVASTATIN CALCIUM 482 465 7 4
LEVOTHYROXINE SODIUM 467 461 8 21
DIOVAN 452 414 9 15
METOPROLOL SUCCINATE 450 441 10 6
SIMVASTATIN 427 414 11 3
ALLOPURINOL 420 397 12 43
CLOPIDOGREL 357 357 13 10
ALENDRONATE SODIUM 339 339 14 41
WARFARIN SODIUM 310 255 15 8
FUROSEMIDE 305 295 16 7
PRAVASTATIN SODIUM 294 276 17 20
NEXIUM 265 251 18 49
BENICAR 254 251 19 50
ATELVIA 231 231 20 157
CARVEDILOL 225 213 21 1
BENAZEPRIL HCL 221 221 22 26
POTASSIUM CHLORIDE 200 200 23 19
NITROSTAT 199 194 24 31
ISOSORBIDE DINITRATE 199 199 24 63
TAMSULOSIN HCL 188 188 26 46
CELEBREX 181 181 27 77
HYDROCHLOROTHIAZIDE 180 180 28 18
MICARDIS 180 180 28 143
LIDODERM 173 170 30 81
CRESTOR 165 163 31 17
DIOVAN HCT 164 155 32 29
LOSARTAN POTASSIUM 159 159 33 11
ATENOLOL 158 152 34 12
QUETIAPINE FUMARATE 143 143 35 223
METFORMIN HCL 141 141 36 25
DILTIAZEM 24HR CD 139 126 37 61
MICARDIS HCT 139 139 37 185
TRIAMTERENE-HCTZ 136 124 39 55
VOLTAREN 134 132 40 107
ZOLPIDEM TARTRATE 133 120 41 34
PANTOPRAZOLE SODIUM 127 127 42 42
SINGULAIR 126 120 43 91
BENICAR HCT 123 123 44 84
AMLODIPINE BESYLATE-BENAZEPRIL 122 122 45 67
CLONIDINE HCL 117 117 46 45
OMEPRAZOLE 115 101 47 23
DONEPEZIL HCL 114 113 48 68
EFFIENT 114 107 48 69
LOVAZA 106 101 50 39
MULTAQ 103 103 51 57
MEGESTROL ACETATE 103 103 R 51 126
SPIRIVA 99 99 53 97
EVISTA 92 92 54 134
TRIAMCINOLONE ACETONIDE 87 86 55 96
GABAPENTIN 83 71 56 51
LOSARTAN-HYDROCHLOROTHIAZIDE 82 80 57 38
MELOXICAM 79 74 58 73
GLIMEPIRIDE 79 68 58 66
GLIPIZIDE 79 79 58 75
LIPITOR 76 74 61 30
ACTONEL 68 68 62 117
METOPROLOL TARTRATE 68 68 62 9
PRADAXA 65 62 64 27
CEPHALEXIN 63 63 65 138
GLYBURIDE-METFORMIN HCL 63 63 R 65 132
JANUVIA 62 62 67 64
TRICOR 61 61 68 94
MONTELUKAST SODIUM 61 59 68 135
COREG CR 60 47 70 83
NATEGLINIDE 60 60 70 160
AZOR 59 59 72 125
AZITHROMYCIN 58 55 73 76
BONIVA 56 56 74 167
WELCHOL 56 50 74 103
BYSTOLIC 56 56 74 32
DILTIAZEM 24HR ER 55 55 77 52
ACTOS 53 53 78 92
ONGLYZA 52 50 79 180
NIFEDIPINE ER 51 51 80 59
TERAZOSIN HCL 50 50 81 116
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.